| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123867 | European Journal of Cancer | 2010 | 8 Pages |
Abstract
Z-360 is safe and well tolerated when combined with gemcitabine. A Phase III trial is needed to determine whether the combination of Z-360 and gemcitabine is superior to gemcitabine alone in advanced PC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Meyer, M.E. Caplin, D.H. Palmer, J.W. Valle, M. Larvin, J.S. Waters, F. Coxon, I. Borbath, M. Peeters, E. Nagano, H. Kato,